{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:13:08Z","timestamp":1789153988373,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    This study investigates the association of platelet count (PLT), mean platelet volume (MPV), and platelet distribution width (PDW) with liver fibrosis and hepatic inflammatory activity in nonalcoholic fatty liver disease (NAFLD) and evaluate their noninvasive biomarker potential. This retrospective case-control study included 117 biopsy-confirmed NAFLD patients and 108 healthy controls. NAFLD patients were stratified by METAVIR scoring system fibrosis stage (F0\u2013F4) and inflammatory activity grade (A0\u2013A3). Platelet parameters, biochemical markers, and fibrosis markers were compared. Correlations were assessed using Spearman analysis, and multivariate logistic regression identified independent risk factors. NAFLD patients had lower PLT and higher MPV\/PDW levels than controls (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). PLT negatively correlated with fibrosis stage (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.640) and inflammatory grade (\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u2005\u22120.556), while MPV (fibrosis:\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.523; inflammation:\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.319) and PDW (fibrosis:\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.417; inflammation:\n                    <jats:italic toggle=\"yes\">r<\/jats:italic>\n                    \u2005=\u20050.440) showed positive correlations (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01). Decreased PLT, increased MPV, PDW, alanine aminotransferase, aspartate aminotransferase, and procollagen type III N-terminal peptide were independent risk factors for fibrosis progression. Increased PDW, alanine aminotransferase, total cholesterol, hyaluronic acid, and procollagen type III N-terminal peptide were independent risk factors for inflammatory exacerbation (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Altered platelet parameters (decreased PLT, increased MPV\/PDW) in NAFLD patients correlate with, and independently predict, the severity of liver fibrosis and inflammation. These routine hematological indices show promise as noninvasive biomarkers for NAFLD assessment, warranting further prospective validation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043815","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:00:19Z","timestamp":1755543619000},"page":"e43815","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between PLT, MPV, PDW and liver fibrosis and inflammatory activity in patients with NAFLD: A retrospective case-control study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1714-6827","authenticated-orcid":false,"given":"Zefeng","family":"Zhang","sequence":"first","affiliation":[{"name":"Wuxi Medical College, Jiangnan University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8316-0697","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuxi Medical College, Jiangnan University, Wuxi, China"},{"name":"Department of Clinical Laboratory, Wuxi Fifth People\u2019s Hospital Affiliated to Jiangnan University, Wuxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"e0318847","DOI":"10.1371\/journal.pone.0318847","article-title":"Mean platelet volume as a biomarker for liver fibrosis in patients with non-alcoholic fatty liver disease.","volume":"20","author":"Cho","year":"2025","journal-title":"PLoS One"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"8867985","DOI":"10.1155\/2021\/8867985","article-title":"Plateletcrit and mean platelet volume in the evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients.","volume":"2021","author":"Michalak","year":"2021","journal-title":"Biomed Res Int"},{"key":"R3-20260911","first-page":"264","article-title":"Association between platelet indices and non-alcoholic fatty liverdisease: a systematic review and meta-analysis.","volume":"116","author":"Li","year":"2024","journal-title":"Rev Esp Enferm Dig"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10238-024-01539-1","article-title":"The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"25","author":"Yang","year":"2025","journal-title":"Clin Exp Med"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/ijms24032313","article-title":"Overview of cellular and soluble mediators in systemic inflammation associated with non-alcoholic fatty liver disease.","volume":"24","author":"Marques","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"991393","DOI":"10.3389\/fpubh.2022.991393","article-title":"Association between inflammatory markers and non-alcoholic fatty liver disease in obese children.","volume":"10","author":"Duan","year":"2022","journal-title":"Front Public Health"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/ijms26010306","article-title":"NAFLD and NAFLD related HCC: emerging treatments and clinical trials.","volume":"26","author":"Khare","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease:a systematic review and meta-analysis of 63 studies and 1,201,807 persons.","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: a multicenter study.","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"1388557","DOI":"10.3389\/fnut.2024.1388557","article-title":"Dietary inflammatory index and the risks of non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.3390\/nu15214507","article-title":"Systematic review and meta-analysis: prevalence of non-alcoholic fatty liver disease and liver fibrosis in patients with inflammatory bowel disease.","volume":"15","author":"Navarro","year":"2023","journal-title":"Nutrients"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MCG.0000000000000340","article-title":"Nonalcoholic fatty liver disease and mean platelet volume: a systemic review and meta-analysis.","volume":"50","author":"Madan","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"R13-20260911","first-page":"473","article-title":"Platelet, antiplatelet therapy and metabolic dysfunction-associated steatotic liver disease: a narrative review.","volume":"14","author":"Boccatonda","year":"2024","journal-title":"Life (Basel)"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward.","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/qjmed\/hcs239","article-title":"Liver disease as a cause of thrombocytopenia.","volume":"106","author":"Hancox","year":"2013","journal-title":"QJM"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"615978","DOI":"10.3389\/fmed.2021.615978","article-title":"Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosisand treatment.","volume":"8","author":"Heyens","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/biomedicines13020393","article-title":"Therapeutic targets and approaches to manage inflammation of NAFLD.","volume":"13","author":"Geng","year":"2025","journal-title":"Biomedicines"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"638750","DOI":"10.3389\/fmed.2021.638750","article-title":"Low intra-individual variation in mean platelet volume over time in systemic lupus erythematosus.","volume":"8","author":"Wirestam","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R21-20260911","first-page":"115","article-title":"Association of gender difference to platelet count (PC), mean platelet volume (MPV) and platelet distribution width (PDW) levels in non-alcoholic fatty liverdisease (NAFLD) patients.","volume":"31","author":"Li","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"1041356","DOI":"10.3389\/fimmu.2022.1041356","article-title":"Association of mean platelet volume\/lymphocyteratio with inflammation in non-dialysis patients with chronic kidney disease stages 1-4: a retrospective study.","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5009\/gnl20127","article-title":"Recent epidemiology of nonalcoholic fatty liver disease.","volume":"15","author":"Murag","year":"2021","journal-title":"Gut Liver"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.3390\/cells10123401","article-title":"Progressive liver fibrosis in non-alcoholic fattyliver disease.","volume":"10","author":"Ramai","year":"2021","journal-title":"Cells"},{"key":"R25-20260911","first-page":"272","article-title":"NAFLD fibrosis progression and type 2 diabetes: the hepatic-metabolic interplay.","volume":"14","author":"Cernea","year":"2024","journal-title":"Life (Basel)"},{"key":"R26-20260911","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00508-013-0394-3","article-title":"A new model using platelet indices to predict liverfibrosis in patients with chronic hepatitis B infection.","volume":"125","author":"Ceylan","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"R27-20260911","doi-asserted-by":"crossref","first-page":"101581","DOI":"10.1016\/j.molmet.2022.101581","article-title":"MicroRNAs in non-alcoholic fatty liver disease: progress and perspectives.","volume":"65","author":"Hochreuter","year":"2022","journal-title":"Mol Metab"},{"key":"R28-20260911","doi-asserted-by":"crossref","first-page":"1376894","DOI":"10.3389\/fendo.2024.1376894","article-title":"The predictive role of the platelet-to-lymphocyte ratio for the risk of non-alcoholic fatty liver disease and cirrhosis: a nationwide cross-sectional study.","volume":"15","author":"Yan","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R29-20260911","doi-asserted-by":"crossref","first-page":"1503090","DOI":"10.3389\/fmed.2024.1503090","article-title":"Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease-an observational study.","volume":"11","author":"Fan","year":"2025","journal-title":"Front Med (Lausanne)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:02:33Z","timestamp":1789153353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":29,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043815","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}